Uncategorized
Toku Obtains CE and UKCA Marks for AI Cardiovascular Risk Assessments Through the Eye
SAN DIEGO--(BUSINESS WIRE)--Toku, Inc., a commercial medical device company specializing in AI assessment of retinal images, announced today that it has obtained CE and UKCA Marks for its patented CLAiR technology. This significant milestone underscores Toku’s commitment to maintaining the highest standards of quality and safety and allows access to the Europe and United Kingdom markets. CLAiR provides accurate, affordable, non-invasive evaluation for the risk of cardiovascular disease (CVD) at